pop up description layer
 
 
Symposia Programme
Hall Overview
Organisation Guide
 
EASD Registration Scientific Programme
Mondial

 

NEW ADVANCES, NEW SCIENCE: TAKING OUR UNDERSTANDING OF GLP-1 TO A NEW LEVEL

Lehar 3 & 4 Hall

Tuesday, 29 September 2009, 11:30 – 13:30 print this page

Chairman:

Eleuterio Ferrannini
Professor of Medicine
Pisa University Medical School, IT

 

11.30 - 11.45

Introduction: Challenges in Current Approaches
to T2DM Management
Eleuterio Ferrannini, MD
Professor of Medicine
Pisa University Medical School, IT

 

11.45 - 12.15

Comparative Evaluation of GLP-1 Analogues
and DPP-4 Inhibitors
Bo Ahrén, MD, PhD
Professor of Clinical Metabolism
Lund University, SE

 

12.15 - 12.45

New GLP-1 Science: Investigating Extrapancreatic Effects
Jens Juul Holst, MD
Professor of Medical Physiology
Panum Institute, University of Copenhagen, DK

 

12.45 - 13.15

Evolving Data on Incretin-based Therapies:
A Closer Look at GLP-1 Analogues
Ralph A. DeFronzo, MD
Professor of Medicine
University of Texas Health Science Center, USA

 

13.15 - 13.30

Q&A Session

 

13.30 - 14.30 Lunch

For further information please contact:
Website: www.viennaincretins09.com

Sponsor: Roche (F. Hoffmann-La Roche Ltd)

    Roche

 

         
 
© EASD | Contact | Imprint
ExhibitionSymposia General